Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
So far in 2022 the Pro Medicus Limited (ASX: PME) share price has traced 32% lower. In that time, the Australian Ethical Investment Ltd (ASX: AEF) share price has drifted 63% lower. Ouch!
Today, the Volpara Health Technologies Ltd (ASX: VHT) share price leapt 21% higher after announcing it secured a roll-out of Volpara Risk Pathways and Volpara Analytics to the 350+ sites owned or operated by Radnet Inc (NASDAQ: RDNT).
Amongst the 100 best performing US stocks (i.e. those with 1000% returns or more) are Tesla Inc (NASDAQ: TSLA), NVIDIA (NASDAQ: NVDA) and Netflix Inc (NASDAQ: NFLX). Here are my lessons learned.
The Pro Medicus Ltd (ASX: PME) share price has been falling these past few months despite announcing some big wins. Indeed, investors are asking, is the PME share price is a buy?
The S&P/ASX 200 (INDEXASX:XJO) shed 0.7% on Thursday as the Appen (ASX:APX) share price made headlines on takeover news.
The S&P/ASX 200 (ASX: XJO) was muted in response to Australia’s first interest rate rise in over a decade. Here’s what you need to know.
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
Healthy earnings results from the likes of CSL (ASX:CSL) and Treasury Wine (ASX:TWE) helped push the ASX 200 (ASX:XJO) higher on Wednesday.
An army of ASX shares has been updated the market today with their first-half results for FY22. Here are the seven I like the look of.
